萬春醫藥 BYSI 深 滬
已收盤 02-06 16:00:00 美东时间
1.50
-0.040
-2.60%
華盛通- 最 高1.56
- 今 開1.51
- 成交量 3.29万股
- 最 低 1.50
- 昨 收 1.54
- 總市值 6168.35万
- 52周最高 3.44
- 市盈率 靜 --
- 換手率 0.08%
- 52周最低 0.98
- 委 比 74.87%
- 總股本 4112.23万
- 歷史最高 48.49
- 量 比 1.23
- 振 幅 3.90%
- 歷史最低 0.542
- 每 手 1
- 風險率 0.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Beyondspring Delays Second Closings of Share Sale
Beyondspring ( ($BYSI) ) has issued an announcement. BeyondSpring Inc. announce...
2025-12-16 06:48
BeyondSpring Announces New Post-Hoc Analyses From Global Phase 3 DUBLIN-3 Study, Showing Plinabulin Plus Docetaxel Provides Clinically Meaningful Benefit For Patients With EGFR WT NSQ NSCLC
In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically meaningful improvements in OS, PFS, and ORR, reinforcing Plinabulin as a
2025-12-11 20:07
BeyondSpring Completes $2 Million Securities Agreement
Beyondspring ( ($BYSI) ) has issued an update. BeyondSpring Inc. announced that...
2025-11-22 06:02
BeyondSpring GAAP EPS of -$0.05
BeyondSpring press release (BYSI): Q3 GAAP EPS of -$0.05. More on BeyondSpring BeyondSpring Inc. (BYSI) 2025 Annual Shareholders Meeting (Transcript) Seeking Alpha’s Quant Rating on BeyondSpring Finan...
2025-11-12 20:54
BeyondSpring Q3 EPS $(0.04) Up From $(0.05) YoY
BeyondSpring (NASDAQ:BYSI) reported quarterly losses of $(0.04) per share. This is a 20 percent increase over losses of $(0.05) per share from the same period last year.
2025-11-12 20:12
SEED Therapeutics Secures $6M in Series A-3 Financing
Beyondspring ( ($BYSI) ) has shared an announcement. On September 22, 2025, SEE...
2025-09-23 19:54
Beyondspring Shareholders Ratify Accounting Firm Appointment
The latest announcement is out from Beyondspring ( ($BYSI) ). BeyondSpring Inc....
2025-09-17 04:36
BeyondSpring GAAP EPS of -$0.10
BeyondSpring press release (NASDAQ:BYSI): Q2 GAAP EPS of -$0.10. Cash and cash equivalents: $9.5 million as of June 30, 2025, compared to $2.9 million as of December 2024 More on BeyondSpring Financ...
2025-08-13 22:10
BeyondSpring Q2 EPS $(0.04) Up From $(0.10) YoY
BeyondSpring (NASDAQ:BYSI) reported quarterly losses of $(0.04) per share. This is a 60 percent increase over losses of $(0.10) per share from the same period last year.
2025-08-13 20:04
BeyondSpring Drug Triggers Immune Response in Patients Who Failed Prior Cancer Immunotherapy
BeyondSpring Inc. (NASDAQ:BYSI) today announced publication of a human clinical study in Med (Cell Press) demonstrating that Plinabulin, when combined with radiation and a checkpoint inhibitor, induces
2025-07-07 19:04
